(Cost)effectiveness of the Intervention 'Gezond En Goed Met Elkaar'
Launched by VU UNIVERSITY OF AMSTERDAM · Oct 15, 2024
Trial Information
Current as of November 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying an intervention called "Gezond en goed met elkaar," which aims to help people with limited health literacy improve their overall health and understanding of health information. The researchers want to find out if participating in this program can lead to better health outcomes and a greater ability to understand health-related topics. They will compare the results of people who take part in the program with those who do not.
To be eligible, participants need to be at least 18 years old and should not have serious reading difficulties or language issues that would prevent them from engaging in the program. Those who join the study will participate in the intervention for three months and fill out questionnaires every three months to help track their progress. This is a great opportunity for individuals looking to enhance their health knowledge and overall well-being. The study is currently recruiting participants of all genders within the age range of 18 years and older.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- Exclusion Criteria:
- • analfabetism
- • insufficient language level of Dutch to be able to participate in the intervention
About Vu University Of Amsterdam
VU University Medical Center, part of the Vrije Universiteit Amsterdam, is a leading academic institution dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the center integrates cutting-edge scientific inquiry with clinical practice to develop new treatments and improve patient outcomes. Committed to ethical standards and patient safety, VU University Medical Center fosters a dynamic research environment that attracts top talent and facilitates groundbreaking studies across various medical fields. Through its clinical trials, the institution aims to translate research findings into effective healthcare solutions, ultimately enhancing the quality of care for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amsterdam, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported